Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2012
08/08/2012EP2483281A1 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
08/08/2012EP2483266A1 Compounds for the treatment of dyslipidemia and related diseases
08/08/2012EP2483264A1 Pyrazole derivatives which modulate stearoyl-coa desaturase
08/08/2012EP2483248A1 Crystalline form i rosuvastatin zinc salt
08/08/2012EP2482840A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
08/08/2012EP2482837A2 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/08/2012EP2482832A2 Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry
08/08/2012EP2482829A1 Bifidobacterium longum atcc baa-999 (bl999) and weight control
08/08/2012EP2482812A2 Therapeutic uses of pharmaceutical compositions
08/08/2012EP2334687B9 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
08/08/2012EP2321308B9 Piperidine gpcr agonists
08/08/2012EP2205253B1 Composition and method inhibiting inflammation
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP1910274B1 Phenyl compounds
08/08/2012EP1585518B9 Peptide deformylase inhibitors
08/08/2012EP1458399B1 Pregnane steroids for use in the treatment of cns disorders
08/08/2012EP1322158B1 Sustained release pharmaceutical compositions containing metformin and method of their production
08/08/2012EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
08/08/2012CN1536999B Crystalline forms
08/08/2012CN1439375B Dehydroepiandrosterone treating use and transfer system
08/08/2012CN102628044A RNAi modulation of APOB and uses thereof
08/08/2012CN102627778A A process for the preparation of cross-linked polyallylamines or pharmaceutically acceptable salts thereof
08/08/2012CN102627676A C-aryl glucoside sglt2 inhibitors and method
08/08/2012CN102627624A 4-(4-aminobenzene sulfonamide) phenylacetic acid derivative and preparation method and application thereof
08/08/2012CN102627613A 2-[(4,6-dimethyl pyrimidine-2-)oxyl]-3-cyano-3,3-dibenzyl propionic acid optical isomer, its preparation method and medical application
08/08/2012CN102627610A One type of benzimidazole derivatives and application thereof
08/08/2012CN102627607A 5HT2c receptor modulator compositions and methods of use
08/08/2012CN102626510A Traditional Chinese medicine composite for treating diabetic cardiopathy and preparation method and applications of traditional Chinese medicine composite
08/08/2012CN102626497A Traditional Chinese medicine for treating diabetic foot
08/08/2012CN102626496A Traditional Chinese medicine for treating diabetic gout
08/08/2012CN102626475A Traditional Chinese medicine for treating diabetic gastroparalysis
08/08/2012CN102626467A Traditional Chinese medicine for treating diabetic nephropathy
08/08/2012CN102626456A Traditional Chinese medicine for treating diabetic diarrhea
08/08/2012CN102626452A Hawthorn, radix puerariae, gingko and balsam pear four-in-one flavone capsule
08/08/2012CN102626449A Capsule for treating apoplexy hemiplegia
08/08/2012CN102626440A Traditional Chinese medicine composition for protecting liver and regulating blood fat
08/08/2012CN102626438A Antidiabetic medicament and preparation method
08/08/2012CN102626437A Extraction method of Caragana sibirica extract product and application thereof
08/08/2012CN102626428A Ginkgo leaf extract osmotic pump controlled-release preparation and preparation method thereof
08/08/2012CN102626420A Mixed preparation containing strontium, calcium and vitamin D
08/08/2012CN102626409A Pharmaceutical composition containing 18 amino acids
08/08/2012CN102626407A Application of isodaphnetin compound in preparation of antidiabetic medicines
08/08/2012CN102626406A Application of cembranoid diterpene flexibilide or medicinal salt thereof in preparation of PGC-1alpha inhibitor
08/08/2012CN102626224A Eyesight improving agent composited by wild berries and Chinese medicines and preparation method thereof
08/08/2012CN102225122B Caffeine-free tea polyphenol and preparation method thereof
08/08/2012CN101935346B Mutated human-source fibroblast growth factor and application in treating endocrine diseases
08/08/2012CN101889079B A method for constructing human placental mesenchymal cells library which is suitable for clinical applicationc
08/08/2012CN101885784B Method for producing glucomannan by liquid culture of konjac cells
08/08/2012CN101828715B Health-care food for patient with hyperlipidemia, hypertension and hypercholesterolemia
08/08/2012CN101822690B Composition of dextran 40 and sodium lactate Ringer' solution and preparation method
08/08/2012CN101757470B Blood fat lowering composition
08/08/2012CN101690795B Tianshen vessel-freeing granules for treating cardiovascular and cerebrovascular diseases
08/08/2012CN101658564B Medicinal plant for treating diabetes mellitus
08/08/2012CN101554406B Extraction process and formulation of mulberry cortex hypoglycemic medicinal active material
08/08/2012CN101543298B Rutin chewing agent and method for preparing same
08/08/2012CN101316840B 1,5-substituted indol-2-yl amide derivatives
08/08/2012CN101313919B Rice fermented with red yeast extract, preparation method and quality detection method thereof
08/08/2012CN101299934B Nutritional formulation for promoting catch-up growth
08/08/2012CN101243053B N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/08/2012CN101195613B Compound with substituted tetratomic ring structure and medicine use thereof
08/08/2012CN101195612B Compound with substituted cyclobutane structure, production method and medicine use thereof
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/07/2012US8236824 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/07/2012US8236810 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV
08/07/2012US8236804 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
08/07/2012US8236789 1-adamantyl azetidin-2-one derivatives and drugs containing same
08/07/2012US8236769 Agent for improving insulin resistance
08/07/2012US8236345 Composition and use
08/07/2012US8236143 Controlling chemical reactions by spectral chemistry and spectral conditioning
08/07/2012CA2649940C Drugs and uses to modulate inflammation, metabolic disorders and other conditions
08/07/2012CA2642465C Novel pyrone-indole derivatives and process for their preparation
08/07/2012CA2543249C Phenyl derivatives as ppar agonists
08/07/2012CA2457652C Soluble t cell receptor
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/07/2012CA2430557C Highly branched soluble glucose polymers and process of obtaining same
08/02/2012WO2012103333A1 Tetrazole compounds and methods of making and using same
08/02/2012WO2012102362A1 Pharmaceutical composition containing drug having poor water solubility
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102308A1 Therapeutic agent and preventive agent for diabetes
08/02/2012WO2012101657A1 Process for preparation of a herbal extract
08/02/2012WO2012101292A1 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor
08/02/2012WO2012101253A1 Pharmaceutical compositions comprising human antibodies to pcsk9
08/02/2012WO2012101124A1 Leptin derivatives
08/02/2012WO2012101068A1 Novel tetrahydroquinoline derivatives
08/02/2012WO2012100734A1 Compounds useful as retinoid-related orphan receptor gamma modulators
08/02/2012WO2012100704A1 Chiral low-toxicity cb1 receptor inhibitor, preparation method therefor, and use thereof
08/02/2012WO2012100612A1 Extraction method, total saponin and use of ilex kudingcha c.j.tseng leaves
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012100441A1 Plant extract composition used for preventing and treating carbohydrate metabolism disorder and preparative method thereof
08/02/2012WO2012100440A1 Plant extract composition used for preventing and treating lipid metabolism disorder and preparative method thereof
08/02/2012WO2012100342A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012WO2012076973A3 Novel salts of dipeptidyl peptidase iv inhibitor
08/02/2012WO2012066365A3 Crystalline pharmaceutically active ingredients
08/02/2012US20120197067 Nutritional Composition for Equine Reproductive Health
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196938 Beta 2 Adrenergic Receptor Agonists Such As Terbutaline for Use in the Treatment of Nocturnal Hypoglycemia
08/02/2012US20120196934 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
08/02/2012US20120196932 Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 1298